PACAomicsIdentification of Diagnosis Biomarkers for Therapeutic Response in Pancreatic Cancer
This study aims to identify diagnostic biomarkers for therapeutic response in pancreatic cancer through genomics, transcriptomics, and proteomics analyses.
suspected pancreatic tumor
Digestive System Diseases+5
+ Digestive System Neoplasms
+ Endocrine System Diseases
Other Study
Summary
Study start date: February 1, 2012
Actual date on which the first participant was enrolled.Pancreatic cancer is a severe form of cancer that is often challenging to treat. Many patients are diagnosed when the cancer is already advanced or has spread to other parts of the body, with an average survival time of 12 months. This research aims to identify biomarkers, or biological indicators, that can help diagnose pancreatic cancer and predict how well a patient will respond to treatment. The importance of this study lies in its potential to improve the understanding and management of pancreatic cancer, which could ultimately lead to better patient outcomes. In this study, researchers collect pancreatic tumor cells through a microbiopsy guided by ultrasound-endoscopy, a minimally invasive procedure. They also gather blood cells for analysis. The primary goal is to perform molecular analyses, including genomics, transcriptomics, and proteomics, to determine the presence or absence of specific biomarkers. These analyses could potentially provide valuable insights into the disease and pave the way for more personalized treatment approaches.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.274 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location